Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.
- Conditions
- LumbagoLow Back PainModic I Discopathy
- Interventions
- Drug: Hydrocortancyl.
- Registration Number
- NCT01694134
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
The treatment of chronic low back pain is a major objective of public healthcare, because it causes an important number of sick leaves. A correlation between clinical observations and an inflammatory discopathy has been underlined, but there is currently any reference treatment. In this study, the main objective is to assess the efficacy of an intradiscal injection of corticoids versus local anaesthetic on the treatment of pain of patients with low back pain associated to a Modic I discopathy.
- Detailed Description
This is a randomized, controlled, single-blind with two arms (anaesthetic versus corticoids) trial.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Age between 18 and 80 years
- Signed Informed consent
- Low back pain for more than 6 months associated with Modic I discopathy (diagnosed by MRI)
- Past history of lumbar surgery
- Patient under anticoagulant or antisludge treatment, or with coagulation troubles
- Patient with unbalanced diabetes mellitus (blood glucose > 1.30 g/l)
- Patient with unstabilized high blood pressure (> 160/95 mmHg)
- Patient with evolving infection
- Patient with iodine allergy or one of the Hydrocortancyl® or Lidocaine components
- Porphyria, hypersensitivity to local anaesthetic
- Patient with sphincter troubles showing a cauda equine syndrome
- Untreated psychotic state
- Pregnant women or of childbearing age without effective contraception means
- Impossible 6 months follow-up
- Participation to another trial
- Vulnerable persons protected by the law
- Persons under guardianship
- Persons unable to express their consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Corticoids Hydrocortancyl. A group of patients will receive an intradiscal injection of Hydrocortancyl. Local anaesthetic Lidocaine A group of patients will receive an intradiscal injection of Lidocaine.
- Primary Outcome Measures
Name Time Method Pain assessment: VAS 1 month The pain will be assessed by the visual analog scale (VAS).
- Secondary Outcome Measures
Name Time Method Pain assessment: VAS 1 week, 2 weeks, 3 weeks, 3 months, 6 months The pain will be assessed by the visual analog scale (VAS).
Specific low back pain parameters assessment 1 month, 3 months,6 months Low back pain parameters will be assessed by the Oswestry scale. The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic. The patient then checks the statement which most closely resembles their situation. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Employment status 1 month, 3 months,6 months Employment or non-employment status will be noted
Quality of life assessment: SF-36 1 month, 3 months, 6 months Quality of life will be assessed by the self-questionnaire SF-36.
Consumption of analgesics and NSAIDs assessment 1 month, 3 months,6 months
Trial Locations
- Locations (1)
Hospital University of Montpellier
🇫🇷Montpellier, France